{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T16:28:53Z","timestamp":1772987333681,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T00:00:00Z","timestamp":1637452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T00:00:00Z","timestamp":1637452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["309648\/2019-0"],"award-info":[{"award-number":["309648\/2019-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["431254\/2018-4"],"award-info":[{"award-number":["431254\/2018-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s11030-021-10350-z","type":"journal-article","created":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T07:02:37Z","timestamp":1637478157000},"page":"2523-2534","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["PTML modeling for peptide discovery: in silico design of non-hemolytic peptides with antihypertensive activity"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1928-853X","authenticated-orcid":false,"given":"Valeria V.","family":"Kleandrova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8877-1592","authenticated-orcid":false,"given":"Julio A.","family":"Rojas-Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4863-8057","authenticated-orcid":false,"given":"Marcus T.","family":"Scotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9544-9016","authenticated-orcid":false,"given":"Alejandro","family":"Speck-Planche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,21]]},"reference":[{"key":"10350_CR1","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1097\/HJH.0000000000002021","volume":"37","author":"BM Egan","year":"2019","unstructured":"Egan BM, Kjeldsen SE, Grassi G, Esler M, Mancia G (2019) The global burden of hypertension exceeds 1.4 billion people: should a systolic blood pressure target below 130 become the universal standard? J Hypertens 37:1148\u20131153. https:\/\/doi.org\/10.1097\/HJH.0000000000002021","journal-title":"J Hypertens"},{"key":"10350_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","volume":"134","author":"KT Mills","year":"2016","unstructured":"Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, He J (2016) Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation 134:441\u2013450. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.018912","journal-title":"Circulation"},{"key":"10350_CR3","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1097\/hjh.0b013e3283282f65","volume":"27","author":"M Pereira","year":"2009","unstructured":"Pereira M, Lunet N, Azevedo A, Barros H (2009) Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens 27:963\u2013975. https:\/\/doi.org\/10.1097\/hjh.0b013e3283282f65","journal-title":"J Hypertens"},{"key":"10350_CR4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.cjca.2015.01.009","volume":"31","author":"DT Lackland","year":"2015","unstructured":"Lackland DT, Weber MA (2015) Global burden of cardiovascular disease and stroke: hypertension at the core. Can J Cardiol 31:569\u2013571. https:\/\/doi.org\/10.1016\/j.cjca.2015.01.009","journal-title":"Can J Cardiol"},{"key":"10350_CR5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1080\/14656566.2017.1333599","volume":"18","author":"I Hernandorena","year":"2017","unstructured":"Hernandorena I, Duron E, Vidal JS, Hanon O (2017) Treatment options and considerations for hypertensive patients to prevent dementia. Expert Opin Pharmacother 18:989\u20131000. https:\/\/doi.org\/10.1080\/14656566.2017.1333599","journal-title":"Expert Opin Pharmacother"},{"key":"10350_CR6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.phrs.2017.07.026","volume":"124","author":"S Laurent","year":"2017","unstructured":"Laurent S (2017) Antihypertensive drugs. Pharmacol Res 124:116\u2013125. https:\/\/doi.org\/10.1016\/j.phrs.2017.07.026","journal-title":"Pharmacol Res"},{"key":"10350_CR7","doi-asserted-by":"publisher","unstructured":"JSH (2014) Chapter 5. Treatment with antihypertensive drugs. Hypertens Res 37:291\u2013300. https:\/\/doi.org\/10.1038\/hr.2014.8","DOI":"10.1038\/hr.2014.8"},{"key":"10350_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j5542","volume":"359","author":"AA Markovitz","year":"2017","unstructured":"Markovitz AA, Mack JA, Nallamothu BK, Ayanian JZ, Ryan AM (2017) Incremental effects of antihypertensive drugs: instrumental variable analysis. BMJ 359:j5542. https:\/\/doi.org\/10.1136\/bmj.j5542","journal-title":"BMJ"},{"key":"10350_CR9","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1111\/1750-3841.13840","volume":"82","author":"M Mirzapour","year":"2017","unstructured":"Mirzapour M, Rezaei K, Sentandreu MA (2017) Identification of potent ACE inhibitory peptides from wild almond proteins. J Food Sci 82:2421\u20132431. https:\/\/doi.org\/10.1111\/1750-3841.13840","journal-title":"J Food Sci"},{"key":"10350_CR10","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3390\/nu9040316","volume":"9","author":"C Daskaya-Dikmen","year":"2017","unstructured":"Daskaya-Dikmen C, Yucetepe A, Karbancioglu-Guler F, Daskaya H, Ozcelik B (2017) Angiotensin-I-Converting Enzyme (ACE)-inhibitory peptides from plants. Nutrients 9:316. https:\/\/doi.org\/10.3390\/nu9040316","journal-title":"Nutrients"},{"key":"10350_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/B978-0-12-416003-3.00016-0","volume":"65","author":"SK Kim","year":"2012","unstructured":"Kim SK, Ngo DH, Vo TS (2012) Marine fish-derived bioactive peptides as potential antihypertensive agents. Adv Food Nutr Res 65:249\u2013260. https:\/\/doi.org\/10.1016\/B978-0-12-416003-3.00016-0","journal-title":"Adv Food Nutr Res"},{"key":"10350_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197644","volume":"14","author":"SM Auwal","year":"2019","unstructured":"Auwal SM, Zainal Abidin N, Zarei M, Tan CP, Saari N (2019) Identification, structure-activity relationship and in silico molecular docking analyses of five novel angiotensin I-converting enzyme (ACE)-inhibitory peptides from stone fish (Actinopyga lecanora) hydrolysates. PLoS ONE 14:e0197644. https:\/\/doi.org\/10.1371\/journal.pone.0197644","journal-title":"PLoS ONE"},{"key":"10350_CR13","doi-asserted-by":"publisher","first-page":"14077","DOI":"10.3390\/ijms150814077","volume":"15","author":"M Darewicz","year":"2014","unstructured":"Darewicz M, Borawska J, Vegarud GE, Minkiewicz P, Iwaniak A (2014) Angiotensin I-converting enzyme (ACE) inhibitory activity and ACE inhibitory peptides of salmon (Salmo salar) protein hydrolysates obtained by human and porcine gastrointestinal enzymes. Int J Mol Sci 15:14077\u201314101. https:\/\/doi.org\/10.3390\/ijms150814077","journal-title":"Int J Mol Sci"},{"key":"10350_CR14","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.3390\/molecules24142541","volume":"24","author":"DY Pujiastuti","year":"2019","unstructured":"Pujiastuti DY, Ghoyatul Amin MN, Alamsjah MA, Hsu JL (2019) Marine Organisms as potential sources of bioactive peptides that inhibit the activity of Angiotensin I-converting enzyme: a review. Molecules 24:2541. https:\/\/doi.org\/10.3390\/molecules24142541","journal-title":"Molecules"},{"key":"10350_CR15","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s00894-010-0862-x","volume":"17","author":"X Wang","year":"2011","unstructured":"Wang X, Wang J, Lin Y, Ding Y, Wang Y, Cheng X, Lin Z (2011) QSAR study on angiotensin-converting enzyme inhibitor oligopeptides based on a novel set of sequence information descriptors. J Mol Model 17:1599\u20131606. https:\/\/doi.org\/10.1007\/s00894-010-0862-x","journal-title":"J Mol Model"},{"key":"10350_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/psc.800","volume":"13","author":"J Wu","year":"2007","unstructured":"Wu J, Aluko RE (2007) Quantitative structure-activity relationship study of bitter di- and tri-peptides including relationship with angiotensin I-converting enzyme inhibitory activity. J Pept Sci 13:63\u201369. https:\/\/doi.org\/10.1002\/psc.800","journal-title":"J Pept Sci"},{"key":"10350_CR17","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1021\/jf051263l","volume":"54","author":"J Wu","year":"2006","unstructured":"Wu J, Aluko RE, Nakai S (2006) Structural requirements of Angiotensin I-converting enzyme inhibitory peptides: quantitative structure-activity relationship study of di- and tripeptides. J Agric Food Chem 54:732\u2013738. https:\/\/doi.org\/10.1021\/jf051263l","journal-title":"J Agric Food Chem"},{"key":"10350_CR18","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1002\/cbdv.200790206","volume":"4","author":"B Spasov","year":"2007","unstructured":"Spasov B, Hall LH (2007) Modeling dipeptides as ACE inhibitors and bitter-tasting compounds by means of E-state structure-information representation. Chem Biodivers 4:2528\u20132539. https:\/\/doi.org\/10.1002\/cbdv.200790206","journal-title":"Chem Biodivers"},{"key":"10350_CR19","doi-asserted-by":"publisher","first-page":"H243","DOI":"10.1111\/j.1750-3841.2009.01301.x","volume":"74","author":"M Foltz","year":"2009","unstructured":"Foltz M, Van Buren L, Klaffke W, Duchateau GSMJE (2009) Modeling of the relationship between dipeptide structure and dipeptide stability, permeability, and ACE inhibitory activity. J Food Sci 74:H243\u2013H251. https:\/\/doi.org\/10.1111\/j.1750-3841.2009.01301.x","journal-title":"J Food Sci"},{"key":"10350_CR20","doi-asserted-by":"publisher","first-page":"9774","DOI":"10.1021\/acs.jafc.7b03367","volume":"65","author":"B Deng","year":"2017","unstructured":"Deng B, Ni X, Zhai Z, Tang T, Tan C, Yan Y, Deng J, Yin Y (2017) New Quantitative structure-activity relationship model for angiotensin-converting enzyme inhibitory dipeptides based on integrated descriptors. J Agric Food Chem 65:9774\u20139781. https:\/\/doi.org\/10.1021\/acs.jafc.7b03367","journal-title":"J Agric Food Chem"},{"key":"10350_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.nutres.2017.07.009","volume":"46","author":"VR Vukic","year":"2017","unstructured":"Vukic VR, Vukic DV, Milanovic SD, Ilicic MD, Kanuric KG, Johnson MS (2017) In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I-converting enzyme inhibitory activity. Nutr Res 46:22\u201330. https:\/\/doi.org\/10.1016\/j.nutres.2017.07.009","journal-title":"Nutr Res"},{"key":"10350_CR22","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.4155\/fmc-2017-0300","volume":"10","author":"TS Win","year":"2018","unstructured":"Win TS, Schaduangrat N, Prachayasittikul V, Nantasenamat C, Shoombuatong W (2018) PAAP: a web server for predicting antihypertensive activity of peptides. Future Med Chem 10:1749\u20131767. https:\/\/doi.org\/10.4155\/fmc-2017-0300","journal-title":"Future Med Chem"},{"key":"10350_CR23","doi-asserted-by":"publisher","first-page":"D444","DOI":"10.1093\/nar\/gkt1008","volume":"42","author":"A Gautam","year":"2014","unstructured":"Gautam A, Chaudhary K, Singh S, Joshi A, Anand P, Tuknait A, Mathur D, Varshney GC, Raghava GP (2014) Hemolytik: a database of experimentally determined hemolytic and non-hemolytic peptides. Nucleic Acids Res 42:D444-449. https:\/\/doi.org\/10.1093\/nar\/gkt1008","journal-title":"Nucleic Acids Res"},{"key":"10350_CR24","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gku1141","volume":"43","author":"R Kumar","year":"2015","unstructured":"Kumar R, Chaudhary K, Sharma M, Nagpal G, Chauhan JS, Singh S, Gautam A, Raghava GP (2015) AHTPDB: a comprehensive platform for analysis and presentation of antihypertensive peptides. Nucleic Acids Res 43:D956-962. https:\/\/doi.org\/10.1093\/nar\/gku1141","journal-title":"Nucleic Acids Res"},{"key":"10350_CR25","doi-asserted-by":"publisher","first-page":"D1104","DOI":"10.1093\/nar\/gkv1174","volume":"44","author":"M Pirtskhalava","year":"2016","unstructured":"Pirtskhalava M, Gabrielian A, Cruz P, Griggs HL, Squires RB, Hurt DE, Grigolava M, Chubinidze M, Gogoladze G, Vishnepolsky B, Alekseyev V, Rosenthal A, Tartakovsky M (2016) DBAASP vol 2: an enhanced database of structure and antimicrobial\/cytotoxic activity of natural and synthetic peptides. Nucleic Acids Res 44:D1104-1112. https:\/\/doi.org\/10.1093\/nar\/gkv1174","journal-title":"Nucleic Acids Res"},{"key":"10350_CR26","unstructured":"LANL (1994\u20132018) Format Converter (HIV Sequence Database), https:\/\/www.hiv.lanl.gov\/content\/sequence\/FORMAT_CONVERSION\/form.html"},{"key":"10350_CR27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12859-015-0586-0","volume":"16","author":"YB Ruiz-Blanco","year":"2015","unstructured":"Ruiz-Blanco YB, Paz W, Green J, Marrero-Ponce Y (2015) ProtDCal: A program to compute general-purpose-numerical descriptors for sequences and 3D-structures of proteins. BMC Bioinform 16:162. https:\/\/doi.org\/10.1186\/s12859-015-0586-0","journal-title":"BMC Bioinform"},{"key":"10350_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/9783527613106","volume-title":"Handbook of Molecular Descriptors","author":"R Todeschini","year":"2000","unstructured":"Todeschini R, Consonni V (2000) Handbook of Molecular Descriptors. WILEY-VCH Verlag GmbH, Weinheim, New York, Chichester, Brisbane, Singapore, Toronto"},{"key":"10350_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.neuropharm.2015.12.019","volume":"103","author":"FJ Romero-Duran","year":"2016","unstructured":"Romero-Duran FJ, Alonso N, Yanez M, Caamano O, Garcia-Mera X, Gonzalez-Diaz H (2016) Brain-inspired cheminformatics of drug-target brain interactome, synthesis, and assay of TVP1022 derivatives. Neuropharmacology 103:270\u2013278. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.12.019","journal-title":"Neuropharmacology"},{"key":"10350_CR30","doi-asserted-by":"publisher","first-page":"17035","DOI":"10.3390\/ijms150917035","volume":"15","author":"FJ Romero Duran","year":"2014","unstructured":"Romero Duran FJ, Alonso N, Caamano O, Garcia-Mera X, Yanez M, Prado-Prado FJ, Gonzalez-Diaz H (2014) Prediction of multi-target networks of neuroprotective compounds with entropy indices and synthesis, assay, and theoretical study of new asymmetric 1,2-rasagiline carbamates. Int J Mol Sci 15:17035\u201317064. https:\/\/doi.org\/10.3390\/ijms150917035","journal-title":"Int J Mol Sci"},{"key":"10350_CR31","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1021\/cn400111n","volume":"4","author":"N Alonso","year":"2013","unstructured":"Alonso N, Caamano O, Romero-Duran FJ, Luan F, Cordeiro MNDS, Yanez M, Gonzalez-Diaz H, Garcia-Mera X (2013) Model for high-throughput screening of multitarget drugs in chemical neurosciences: synthesis, assay, and theoretic study of rasagiline carbamates. ACS Chem Neurosci 4:1393\u20131403. https:\/\/doi.org\/10.1021\/cn400111n","journal-title":"ACS Chem Neurosci"},{"key":"10350_CR32","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.ejmech.2011.02.072","volume":"46","author":"G Marzaro","year":"2011","unstructured":"Marzaro G, Chilin A, Guiotto A, Uriarte E, Brun P, Castagliuolo I, Tonus F, Gonzalez-Diaz H (2011) Using the TOPS-MODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors. Eur J Med Chem 46:2185\u20132192. https:\/\/doi.org\/10.1016\/j.ejmech.2011.02.072","journal-title":"Eur J Med Chem"},{"key":"10350_CR33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/1567205011310020001","volume":"10","author":"A Speck-Planche","year":"2013","unstructured":"Speck-Planche A, Kleandrova VV, Luan F, Cordeiro MNDS (2013) Multi-target inhibitors for proteins associated with Alzheimer: In silico discovery using fragment-based descriptors. Curr Alzheimer Res 10:117\u2013124. https:\/\/doi.org\/10.2174\/1567205011310020001","journal-title":"Curr Alzheimer Res"},{"key":"10350_CR34","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1039\/c2mb25093d","volume":"8","author":"A Speck-Planche","year":"2012","unstructured":"Speck-Planche A, Kleandrova VV, Luan F, Cordeiro MNDS (2012) A ligand-based approach for the in silico discovery of multi-target inhibitors for proteins associated with HIV infection. Mol Biosyst 8:2188\u20132196. https:\/\/doi.org\/10.1039\/c2mb25093d","journal-title":"Mol Biosyst"},{"key":"10350_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11030-011-9337-y","volume":"16","author":"A Speck-Planche","year":"2012","unstructured":"Speck-Planche A, Kleandrova VV (2012) In silico design of multi-target inhibitors for C-C chemokine receptors using substructural descriptors. Mol Divers 16:183\u2013191. https:\/\/doi.org\/10.1007\/s11030-011-9337-y","journal-title":"Mol Divers"},{"key":"10350_CR36","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1021\/acs.jcim.5b00630","volume":"56","author":"A Speck-Planche","year":"2016","unstructured":"Speck-Planche A, Kleandrova VV, Ruso JM, Cordeiro MNDS (2016) First multitarget chemo-bioinformatic model to enable the discovery of antibacterial peptides against multiple Gram-positive pathogens. J Chem Inf Model 56:588\u2013598. https:\/\/doi.org\/10.1021\/acs.jcim.5b00630","journal-title":"J Chem Inf Model"},{"key":"10350_CR37","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1021\/acscombsci.6b00063","volume":"18","author":"VV Kleandrova","year":"2016","unstructured":"Kleandrova VV, Ruso JM, Speck-Planche A, Cordeiro MNDS (2016) Enabling the discovery and virtual screening of potent and safe antimicrobial peptides. simultaneous prediction of antibacterial activity and cytotoxicity. ACS Comb Sci 18:490\u2013498. https:\/\/doi.org\/10.1021\/acscombsci.6b00063","journal-title":"ACS Comb Sci"},{"key":"10350_CR38","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/978-0-387-84858-7_15","volume-title":"The elements of statistical learning: data mining, inference, and prediction","author":"T Hastie","year":"2009","unstructured":"Hastie T, Tibshirani R, Friedman J (2009) Random forests. In: Hastie T, Tibshirani R, Friedman J (eds) The elements of statistical learning: data mining, inference, and prediction. Springer, New York, New York, NY, pp 587\u2013604"},{"key":"10350_CR39","unstructured":"TIBCO-Software-Inc. (2018) STATISTICA (Data Analysis Software System). v13.5.0.17, http:\/\/tibco.com, Palo Alto, California, USA"},{"key":"10350_CR40","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1098\/rspl.1895.0041","volume":"58","author":"K Pearson","year":"1895","unstructured":"Pearson K (1895) Notes on regression and inheritance in the case of two parents. Proc R Soc Lond 58:240\u2013242. https:\/\/doi.org\/10.1098\/rspl.1895.0041","journal-title":"Proc R Soc Lond"},{"key":"10350_CR41","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/0005-2795(75)90109-9","volume":"405","author":"BW Matthews","year":"1975","unstructured":"Matthews BW (1975) Comparison of the predicted and observed secondary structure of T4 phage lysozyme. Biochim Biophys Acta 405:442\u2013451. https:\/\/doi.org\/10.1016\/0005-2795(75)90109-9","journal-title":"Biochim Biophys Acta"},{"key":"10350_CR42","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.3390\/molecules17054791","volume":"17","author":"F Sahigara","year":"2012","unstructured":"Sahigara F, Mansouri K, Ballabio D, Mauri A, Consonni V, Todeschini R (2012) Comparison of different approaches to define the applicability domain of QSAR models. Molecules 17:4791\u20134810. https:\/\/doi.org\/10.3390\/molecules17054791","journal-title":"Molecules"},{"key":"10350_CR43","doi-asserted-by":"publisher","first-page":"14704","DOI":"10.1021\/acsomega.8b02419","volume":"3","author":"A Speck-Planche","year":"2018","unstructured":"Speck-Planche A (2018) Combining ensemble learning with a fragment-based topological approach to generate new molecular diversity in drug discovery: in silico design of hsp90 inhibitors. ACS Omega 3:14704\u201314716. https:\/\/doi.org\/10.1021\/acsomega.8b02419","journal-title":"ACS Omega"},{"key":"10350_CR44","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.2174\/1568026611209061734","volume":"12","author":"A Speck-Planche","year":"2012","unstructured":"Speck-Planche A, Kleandrova VV (2012) QSAR and molecular docking techniques for the discovery of potent monoamine oxidase B inhibitors: Computer-aided generation of new rasagiline bioisosteres. Curr Top Med Chem 12:1734\u20131747. https:\/\/doi.org\/10.2174\/1568026611209061734","journal-title":"Curr Top Med Chem"},{"key":"10350_CR45","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1021\/acsomega.8b03693","volume":"4","author":"A Speck-Planche","year":"2019","unstructured":"Speck-Planche A (2019) Multicellular target QSAR model for simultaneous prediction and design of anti-pancreatic cancer agents. ACS Omega 4:3122\u20133132. https:\/\/doi.org\/10.1021\/acsomega.8b03693","journal-title":"ACS Omega"},{"key":"10350_CR46","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1568026619666190122151634","volume":"19","author":"Q Wu","year":"2019","unstructured":"Wu Q, Ke H, Li D, Wang Q, Fang J, Zhou J (2019) Recent progress in machine learning-based prediction of peptide activity for drug discovery. Curr Top Med Chem 19:4\u201316. https:\/\/doi.org\/10.2174\/1568026619666190122151634","journal-title":"Curr Top Med Chem"},{"key":"10350_CR47","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1016\/j.bmc.2017.07.012","volume":"26","author":"EY Lee","year":"2018","unstructured":"Lee EY, Wong GCL, Ferguson AL (2018) Machine learning-enabled discovery and design of membrane-active peptides. Bioorg Med Chem 26:2708\u20132718. https:\/\/doi.org\/10.1016\/j.bmc.2017.07.012","journal-title":"Bioorg Med Chem"},{"key":"10350_CR48","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1007\/s00253-015-6375-x","volume":"99","author":"JP da Costa","year":"2015","unstructured":"da Costa JP, Cova M, Ferreira R, Vitorino R (2015) Antimicrobial peptides: an alternative for innovative medicines? Appl Microbiol Biotechnol 99:2023\u20132040. https:\/\/doi.org\/10.1007\/s00253-015-6375-x","journal-title":"Appl Microbiol Biotechnol"},{"key":"10350_CR49","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1080\/08927014.2012.728210","volume":"28","author":"P Jorge","year":"2012","unstructured":"Jorge P, Lourenco A, Pereira MO (2012) New trends in peptide-based anti-biofilm strategies: a review of recent achievements and bioinformatic approaches. Biofouling 28:1033\u20131061. https:\/\/doi.org\/10.1080\/08927014.2012.728210","journal-title":"Biofouling"},{"key":"10350_CR50","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.2174\/0929867311320150005","volume":"20","author":"P Zhou","year":"2013","unstructured":"Zhou P, Wang C, Ren Y, Yang C, Tian F (2013) Computational peptidology: a new and promising approach to therapeutic peptide design. Curr Med Chem 20:1985\u20131996. https:\/\/doi.org\/10.2174\/0929867311320150005","journal-title":"Curr Med Chem"},{"key":"10350_CR51","doi-asserted-by":"publisher","first-page":"20160153","DOI":"10.1098\/rsfs.2016.0153","volume":"7","author":"EY Lee","year":"2017","unstructured":"Lee EY, Lee MW, Fulan BM, Ferguson AL, Wong GCL (2017) What can machine learning do for antimicrobial peptides, and what can antimicrobial peptides do for machine learning? Interface Focus 7:20160153. https:\/\/doi.org\/10.1098\/rsfs.2016.0153","journal-title":"Interface Focus"},{"key":"10350_CR52","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.mib.2019.03.004","volume":"51","author":"MT Torres","year":"2019","unstructured":"Torres MT, de la Fuente-Nunez C (2019) Toward computer-made artificial antibiotics. Curr Opin Microbiol 51:30\u201338. https:\/\/doi.org\/10.1016\/j.mib.2019.03.004","journal-title":"Curr Opin Microbiol"},{"key":"10350_CR53","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1046\/j.1365-2443.1997.1020301.x","volume":"2","author":"A Varshavsky","year":"1997","unstructured":"Varshavsky A (1997) The N-end rule pathway of protein degradation. Genes Cells 2:13\u201328. https:\/\/doi.org\/10.1046\/j.1365-2443.1997.1020301.x","journal-title":"Genes Cells"},{"key":"10350_CR54","doi-asserted-by":"publisher","first-page":"12512","DOI":"10.1038\/srep12512","volume":"5","author":"R Kumar","year":"2015","unstructured":"Kumar R, Chaudhary K, Singh Chauhan J, Nagpal G, Kumar R, Sharma M, Raghava GP (2015) An in silico platform for predicting, screening and designing of antihypertensive peptides. Sci Rep 5:12512. https:\/\/doi.org\/10.1038\/srep12512","journal-title":"Sci Rep"},{"key":"10350_CR55","doi-asserted-by":"publisher","first-page":"22843","DOI":"10.1038\/srep22843","volume":"6","author":"K Chaudhary","year":"2016","unstructured":"Chaudhary K, Kumar R, Singh S, Tuknait A, Gautam A, Mathur D, Anand P, Varshney GC, Raghava GP (2016) A web server and mobile app for computing hemolytic potency of peptides. Sci Rep 6:22843. https:\/\/doi.org\/10.1038\/srep22843","journal-title":"Sci Rep"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-021-10350-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-021-10350-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-021-10350-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T12:06:55Z","timestamp":1664885215000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-021-10350-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,21]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10350"],"URL":"https:\/\/doi.org\/10.1007\/s11030-021-10350-z","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,21]]},"assertion":[{"value":"14 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}